• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Imaging Dynamics picks up partners

Article

Digital x-ray developer Imaging Dynamics Corp. (IDC) has put together two deals: one a software development and licensing agreement with Analogic, and the other a supply, sales, and service arrangement with fellow Canadian ALI Technologies. Analogic will

Digital x-ray developer Imaging Dynamics Corp. (IDC) has put together two deals: one a software development and licensing agreement with Analogic, and the other a supply, sales, and service arrangement with fellow Canadian ALI Technologies. Analogic will provide image algorithm and processing software that will be integrated into IDC’s Xplorer 1700 digital x-ray system. Specifically, these algorithms address image segmentation and contrast optimization. Conversely, ALI will provide workstation software to be incorporated into Xplorer 1700. ALI will also provide direct sales and service to Imaging Dynamics’ customers for image management and archiving, and will serve as a marketing channel for the Xplorer product.

Recent Videos
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 2
Related Content
© 2025 MJH Life Sciences

All rights reserved.